Kings Arms Yard VCT PLC

Kings Arms Yard VCT PLC functions as a venture capital trust, primarily allocating capital to private, unquoted companies and those listed on the Alternative Investment Market (AIM). Its key investment areas are information and communication technologies (ICT) and healthcare. The trust exclusively invests within the United Kingdom, utilizing a range of securities, including shares and debt instruments with maturity periods of five years or more. A portion of its assets is also held in publicly traded equities and fixed-interest securities. The fund explicitly excludes investments in businesses operating in real estate, securities trading, insurance, banking, or agriculture. Strict financial criteria apply to portfolio companies: their gross assets must not surpass £15 million ($17.39 million) immediately before investment, nor £16 million ($18.55 million) immediately after. Additionally, no single portfolio company can receive more than £5 million ($5.80 million) from State-aided risk capital schemes within any given twelve-month period, and they are permitted to employ a maximum of 250 individuals.

Kings Arms Yard VCT PLC trades as KAY.L on LSE. The company is classified in Financial Services / Asset Management and reports in GBP.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £2.10M of revenue and £2.14M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Kings Arms Yard VCT PLC can be compared against peers such as Vanguard LifeStrategy 100% Equity Fund A Inc, Albion Development VCT PLC, Albion Venture Capital Trust PLC, Artemis UK Future Leaders Ord, Alpha Real Trust Limited, Artemis Alpha Trust plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £105.88M, beta of -0.01, and return on equity of +2.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

KAY.L currently shows total debt of £0 and beta of -0.01. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.albion.capital/investor-centre/our-funds/kings-arms-yard-vct-plc

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.